Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

16.75 -0.01 (-0.03%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Summit Therapeutics Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal ↗

August 19, 2023

Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a...

Via Talk Markets

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 14, 2023

Via Benzinga

Cleveland-Cliffs, United States Steel, monday.com And Other Big Stocks Moving Higher On Monday ↗

August 14, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023

August 09, 2023

From Summit Therapeutics Inc.

Via Business Wire

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 14, 2023

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...

Via Benzinga

Summit Therapeutics to Host Q2 2023 Financial Results & Operational Progress Call on August 9, 2023

August 02, 2023

From Summit Therapeutics Inc.

Via Business Wire

AlloVir, DigitalOcean And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

June 22, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. AlloVir, Inc. (NASDAQ: ALVR) shares dipped 24.1% to $3.74 in pre-market...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 20, 2023

Via Benzinga

Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023

June 04, 2023

From Summit Therapeutics Inc.

Via Business Wire

Ivonescimab Updated Data to be Featured at ASCO 2023

June 01, 2023

From Summit Therapeutics Inc.

Via Business Wire

Why Shares of Summit Therapeutics Slumped on Tuesday ↗

May 16, 2023

The company's shares have been falling since it announced earnings late last week.

Via The Motley Fool

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 16, 2023

Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.

Via Benzinga

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023

May 11, 2023

From Summit Therapeutics Inc.

Via Business Wire

Summit Therapeutics Announces First Patient Treated in Phase III HARMONi Clinical Trial Evaluating Ivonescimab (SMT112)

May 09, 2023

From Summit Therapeutics Inc.

Via Business Wire

Why Shares of Summit Therapeutics Soared This Week ↗

May 05, 2023

Summit Therapeutics advanced its lead therapy into two phase 3 trials to treat non-small cell lung cancer.

Via The Motley Fool

Summit Therapeutics Announces Initial Indications for Clinical Trials for Ivonescimab (SMT112)

May 03, 2023

From Summit Therapeutics Inc.

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Summit Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm

March 21, 2023

From Schall Law Firm

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Summit Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm

March 20, 2023

From The Schall Law Firm

Via Business Wire

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022

March 09, 2023

From Summit Therapeutics Inc.

Via Business Wire

Over $395M Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

March 09, 2023

The Dow Jones closed lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks...

Via Benzinga

Summit Therapeutics Closes Fully-Subscribed $500 Million Rights Offering

March 03, 2023

From Summit Therapeutics Inc.

Via Business Wire

Macy's, Big Lots, Sprouts Farmers Market And Other Big Stocks Moving Higher On Thursday ↗

March 02, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Workday, AdaptHealth And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

February 28, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. AdaptHealth Corp (NASDAQ: AHCO) shares dipped 18.3% to $17.95 in...

Via Benzinga

Summit Therapeutics’ Rights Offering Nearing Expiration Date

February 23, 2023

From Summit Therapeutics Inc.

Via Business Wire

Acurx is Setting a High Bar for New Treatments in C. diff ↗

February 14, 2023

A New Gold Standard for C. diff Therapy Could be in the Offing; Next Data Release Expected in 2Q23

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 03, 2023

Via Benzinga

Ford, Atlassian, Amazon And Other Big Stocks Moving Lower On Friday ↗

February 03, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 03, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

February 03, 2023

Good morning! It's time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday!

Via InvestorPlace

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.